menu search

Markets fall for 3rd day on weak global equities

Benchmark equity indices ended lower on Monday, falling for the third day running, amid weak trends in global markets and spike in Brent crude oil pri...

October 16, 2023, 6:44 pm

Eurusd buyers push price to the 200 hour ma/swing area target.

The EURUSD started the US trading day on a positive note and has continued its upward momentum, reachin...

October 16, 2023, 3:05 pm

What to know about the latest china chip restrictions as the u.s. cracks down

The stocks of microchip and semiconductor companies are volatile today on reports that the Biden admini...

October 16, 2023, 1:46 pm

Bitcoin soars amid new wave of bullishness on crypto etf approvals

and other cryptocurrencies surged Monday on the rising possibility that the Securities and Exchange Com...

October 16, 2023, 9:29 am

Shell hits all-time high as gaza fears boost crude price

Shell shares hit a record high today on fears that an Israeli invasion of Gaza City could send crude pr...

October 16, 2023, 9:28 am

Natural gas price analysis: xng/usd flirts with last week’s swing low, below $3.4500

Natural Gas price extends last week’s retracement slide from a nine-month peak, around the $3.6350-$3.6400 area, and remains under some selling pres...

October 16, 2023, 5:14 am

Aterian climbs 5% on latest exploration news from morocco

Aterian, the Morocco-focused minerals explorer, jumped 5% on some encouraging samples from its Tata project. Shares in the group have been bucking the...

October 16, 2023, 4:08 am

Forexlive asia-pacific fx news wrap: nzd opens and pops higher after weekend election

Fed's Harker speaks Monday on his economic outlookChina's foreign minister Wang Yi meets Russian foreig...

October 16, 2023, 3:49 am

Fed's harker speaks monday on his economic outlook

The times for this seem a little uncertain, it looks like 0630 GMT, which is 1030 US Eastern time: Federal Reserve Bank of Philadelphia President Patr...

October 16, 2023, 3:45 am

Former bank of china chairman arrested

Former Bank of China chairman Liu Liange had been under investigation back in March. He was the first former head of a centrally administered financia...

October 16, 2023, 2:45 am

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm


Search within

Pages Search Results: